0001614107-17-000001.txt : 20170221 0001614107-17-000001.hdr.sgml : 20170221 20170221154728 ACCESSION NUMBER: 0001614107-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 EFFECTIVENESS DATE: 20170221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Faraday Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614107 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-221669 FILM NUMBER: 17624955 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 2064528700 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 D/A 1 primary_doc.xml X0707 D/A LIVE 0001614107 Faraday Pharmaceuticals, Inc. 1616 EASTLAKE AVENUE E. SUITE 560 SEATTLE WA WASHINGTON 98102 206-492-5310 DELAWARE Scion Pharmaceuticals, Inc. None Corporation true 2013 Mark Roth c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter Steven Gillis c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter Stephen Hill c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Paulina Hill c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Thomas King c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Simon Tulloch c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Brian Blackman c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001614107-14-000001 2014-07-09 true true false 0 32780000 32606754 173246 false 11 0 0 0 false Faraday Pharmaceuticals, Inc. /s/ Brian Blackman Brian Blackman Chief Financial and Business Officer 2017-02-21